In keeping with the development of medical technology, treatment methods for diseases are also becoming more sophisticated. However, there are still cases where the timing of diagnosis is missed and a lot of costs are paid for treatment. Couldn’t we prevent diseases in advance by diagnosing them more easily and quickly and treating them at an early stage??

Airs Medical is a startup that provides artificial intelligence (AI)-based healthcare solutions. >Based on deep learning and robotics technology, we are striving to provide an environment where patients can reduce risk and enjoy a healthy life through preemptive management, such as predicting disease or early diagnosis before they get sick. By making the various medical measures required for diagnosis more familiar, we can diagnose the disease a little earlier and predict the next stage of the disease. I have a dream that if we make it possible, we can change the structure of having to spend huge amounts of treatment costs through preemptive management. Not only does it resolve patient inconveniences, provide clinical value to medical staff, We met and talked with Lee Hye-seong, CEO of Airs Medical, who is creating solutions that can help hospital operations

What kind of company is Airs Medical

Airs Medical is a medical artificial intelligence startup that started from Seoul National University's Biomedical Imaging Science Laboratory in 2018, providing artificial intelligence-based healthcare solutions. It is provided. 2021Year MRI Accelerated Image Restoration Solution SwiftMR™(Swift MR) launched to 14 countries, including Korea and the United States. It has entered the above countries and is currently using AIIV (AIIV), an automated solution for venous blood collection. We are accelerating research and development to introduce >) to the market.

Airs Medical's management philosophy is to deliver the highest level of medical services to both medical institutions and patients through digital transformation of the medical experience. Each of the co-founders of Airs Medical has experienced pain themselves or their families. So 'I wish I had found out sooner that my family member was sick', ' span>Every time I get blood drawn, it hurts and is difficult, so I wondered if there was another way' If you look around, new technologies are coming out every day, I felt that the medical field was not fully enjoying the benefits, and that is what I meant. I started Airs Medical to solve problems with the right people..

The characteristic of our products is that they provide value to patients, medical staff, and hospitals. Through this, we hope to take the lead in moving towards a healthier society for all members of society by ensuring that those in need receive appropriate medical services. The problems we are trying to solve are for me and my family, In the end, it is about making it possible for everyone to live a healthier life< span>, Airs Medical is maintaining its competitive edge and growing toward its goals by continuing to widen the technological gap based on its overwhelming technological capabilities proven in the world.

What is your main business and differentiation

Airs Medical is anBased on technologies such as artificial intelligence and robotics, we are creating products that transform hospitals into more efficient and friendly spaces that are helpful to patients. SwiftMR™is a low-quality MRI based on the Deep Learning algorithm. (Magnetic Resonance Imaging) It is software that restores into clear, high-quality images. MRI is a technology with great clinical significance, but the equipment is expensive and the treatment takes anywhere from 30 minutes to depending on the area or purpose of the scan. span>1The disadvantage is that it takes more than an hour to inspect. One of the reasons MRI takes a long time is to obtain more data and produce high-quality images. By applying SwiftMR™'s artificial intelligence technology, you can maximize MRI imaging and scanning time. It shortens the video by >50% and restores low-quality video to a clear, high-quality video with less noise. From the patient's perspective, it can reduce the time spent lying down in the frustrating MRI equipment. >From the perspective of medical staff and hospitals, the efficiency of expensive MRI equipment can be improved. Currently 14countries, including the United States as well as local hospitals in Korea, 270 It has been installed in more than 100 hospitals, and active clinical research is continuing. The goal is to obtain sales approval in more than 20 countries in the second half of 2023.

SwiftMR™ succeeded in commercialization in 2021, generating sales not only domestically but also overseas. is uploading. As it is still in the early stages of entering the market, increasing customers through aggressive sales and investment, Permission( Expanding the accessible market through >approval)is one of the most important tasks this year. About 20 countriesby the end of this year, next year. span>We aim to enter more than 40countries. We plan to quickly increase our market share and at the same time add products that can provide added value.

Also, the International Hospital and Health Tech Expo held at COEX in September 2023 span>AIIV(AIIV) presented by (K-hospital) is an automated venous blood collection solution that combines artificial intelligence and robotics technology. As AIIVis a new concept solution that has never existed in the world,, received a very enthusiastic response at this International Hospital and Health Tech Expo< span>. Through ultrasound exploration and AI analysis, blood vessels are distinguished as clearly as possible, Through sophisticated robotic blood collection, the needle can be accurately penetrated into the target blood vessel even for pediatric and elderly patients who have difficulty collecting blood. By making it possible to draw blood painlessly and accurately in one go, we provide patients with an improved blood collection experience and an efficient medical environment for medical staff. Provide.

AIIV has been doing R&D for 4 years. Although we first introduced the product as a prototype to see the market's response, we are concentrating on the final stages of research and development so that we can present it as a finished product soon. . The goal is to launch domestically in the second half of next year and enter the global market by the first half of next year. In the second half of the year, we will target 10 countries and then expand to 40 countries. We have plans to expand our productsLosing.

What are your future goals

Airs Medical's final goal is to provide both AI-based software and hardware. It is about becoming a pan-healthcare AI solution company. 2021SwiftMR™ After official launch, Currently, it has been installed in more than 270 hospitals in 14 countries. span>Achieved the number of MRI images processedover 10,000. Based on these achievements, it was selected as one of the 15 prospective unicorns for 2023. . Medical AI which is difficult to monetize is attracting attention with remarkable achievements, I always think that this is just the beginning. This is because we believe that there are still many problems that we still have to solve and that can be solved.

One of the main factors that enabled SwiftMR™ to quickly enter the global market is to focus on the global market from product development to aggressive licensing and sales. This was done in parallel with infrastructure construction. Based on this know-how, AIIV is expected to be able to effectively enter the global market once it is officially launched. . Airs Medical is not only growing in Korea but is also recognized in the global market., We are firmly establishing ourselves as a global company through active activities. I want to.

Please introduce what Airs Medical has achieved recently

Recently, Airs Medical not only obtained Japanese Pharmaceutical and Medical Device Act certification(PMDA)5< span>MDSAP (Medical Device Single Audit Program), which is a single audit program for medical devices in each country.Certification and medical AI The industry's first international standard information protection certification3type(ISO/IEC 27001, 27017, 27018) Successively, we have laid the foundation for entering the global market and are carrying out aggressive overseas sales. Also, In the United States, low-field MRI specialists >Signed a strategic collaboration relationship with FONAR Corporation (NASDAQ:FONR). Through this agreement, not only , 1.5T, 3.0T , but also 0.25T, 0.6T < span>Applies SwiftMR™ to original fieldMRI, such as >, In addition to securing various clinical results, MRI emphysema CoverageAchieved success in expanding.

Airs Medical will be holding the largest medical event in North America to be held in Chicago, USA on the 11th and 24th of this coming month. These latest achievements will be presented at RSNA2023, the radiology conference of . This RSNA, there are 2 AI Theater Presentation and 2 research abstracts, we plan to present the results of research conducted at home and abroad and the successful introduction of SwiftMR™< /span>.